Nonetheless, reprogramming of tumour milieu for immunotherapeutical purposes seems to be conceivable because of the plethora of pathophysiological effects played by VEGF on the immune innate and adaptive compartment [160,194], by enhancing the recruitment and proliferation of cancer tolerogenic Tregs cells [195] and tumour associate macrophages (TAM). Here, VEGFA is linked to cancer.